Skip to main content
Premium Trial:

Request an Annual Quote

Navigenics is Almost As Popular As Britney

At VentureBeat, David Hamilton takes a closer look at what, exactly, is Navigenics' plan. While GTO jumped on a recent WSJ article that hyped Navigenics' announcement that they were "launching" their genetic tests next year, Hamilton looks into they fact that right now they’re only taking pre-orders for the testing service, which will scan for SNPs. However, moans Hamilton, they won't make all that data available. "Personally, I’m not that excited about a service that’s going to decide when and how to dole out my own genetic information to me in the form of limited genetic tests," writes Hamilton.

 

 

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.